Results 201 to 210 of about 42,502 (303)

Effect of Shengyang Yiwei Decoction combined with selective serotonin reuptake inhibitor antidepressants on HAMD-17 score and somatic symptoms in patients with depression. [PDF]

Pak J Med Sci
Li L, Wan A, Zhao M, Yu L, Han Y, Mi K.
europepmc   +1 more source

Selective serotonin reuptake inhibitors in depression: An editorial review

Akash Jain
openalex   +2 more sources

14‐3‐3 proteins: Regulators of cardiac excitation–contraction coupling and stress responses

The Journal of Physiology, EarlyView.
Abstract figure legend 14‐3‐3 protein interactions in cardiac regulation. Schematic representation of 14‐3‐3 binding partners in excitation–contraction coupling, transcriptional regulation/development and stress response pathways. Asterisks indicate targets where the exact 14‐3‐3 binding site is unknown.
Heather C. Spooner, Rose E. Dixon
wiley   +1 more source

Selective Serotonin Reuptake Inhibitor [PDF]

, 2020
openaire   +1 more source

Psychotropic medication and the fetal brain

The Journal of Physiology, EarlyView.
Abstract figure legend Brain region changes linked to in‐utero psychotropic exposure. Abstract Medications known to cross the blood–brain barrier (psychotropic medications) are commonly prescribed to women during pregnancy, often for the management of mental illness.
Oliver Gale‐Grant, Tomoki Arichi
wiley   +1 more source

Improvement in Selective Serotonin Reuptake Inhibitor-Associated Sexual Dysfunction With Buspirone: Examining the Evidence. [PDF]

Cureus
Lipman K, Betterly H, Botros M.
europepmc   +1 more source

Safety of Vortioxetine in Patients With Depression: A Post‐Marketing Surveillance Study of Intracranial Hemorrhage in a Japanese Health Insurance Claims Database

Neuropsychopharmacology Reports, Volume 46, Issue 1, March 2026.
This real‐world, retrospective cohort study showed that the incidence of intracranial hemorrhage was low in Japanese patients with depression prescribed vortioxetine, and comparable with that observed in patients prescribed selective serotonin reuptake inhibitors (SSRIs).
Takeshi Inoue, Rie Otake, Tatsuya Hoshino   +2 more
wiley   +1 more source

Incidence of Hematoma Following Breast Reduction in Patients Taking Selective Serotonin Reuptake Inhibitor or Serotonin-Norepinephrine Reuptake Inhibitor: A Retrospective Review. [PDF]

Cureus
Duncan A, Stewart K, Dow T, Williams J.
europepmc   +1 more source

Improvement in avoidance in major depressive disorder: A 10‐month prospective study of depressive symptoms and personality traits

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 1, March 2026.
Abstract Aim Avoidance is a key maintaining factor in major depressive disorder (MDD); however, longitudinal evidence remains limited, and its association with personality traits is not fully understood. This study aimed to (1) examine the longitudinal associations among avoidance, depressive symptoms, and rumination and (2) explore the relationship ...
Ryotaro Higuchi, Atsuo Nakagawa, Dai Mitsuda, Waka Nogami, Mizuki Amano, Sakae Ihara, Aoi Ito, Sachiko Noda, Nariko Katayama, Hiroki Kocha   +9 more
wiley   +1 more source

Neural activation changes following attention bias modification treatment or a selective serotonin reuptake inhibitor for social anxiety disorder. [PDF]

Psychol Med
Azriel O, Arad G, Tik N, Weiser M, Bloch M, Garber E, Lazarov A, Pine DS, Tavor I, Bar-Haim Y.   +9 more
europepmc   +1 more source